FX.co ★ Pacira BioSciences Appoints Shawn Cross As CFO

Pacira BioSciences, Inc. (PCRX), a leading firm dedicated to non-opioid pain management solutions, announced on Monday the appointment of Shawn Cross as its new Chief Financial Officer. Before joining Pacira, Mr. Cross was with Applied Molecular Transport, Inc. (AMT), a pioneering company in the development of innovative oral biological therapies aimed at addressing severe autoimmune, metabolic, and inflammatory diseases. At AMT, he began his tenure as Chief Financial Officer, later advancing to Chief Operating Officer, and subsequently held the position of Chief Executive Officer, during which he led the merger with Cyclo Therapeutics, Inc. (CYTH). Mr. Cross continues to contribute his expertise as a member of Cyclo Therapeutics' Board.